White label ELPA - ClinicalTrials.eu

A study to evaluate how JNJ-77242113 is absorbed by the body in healthy participants for the treatment of inflammatory diseases.

Not recruiting

1 1 1
Investigated diseases:
- Inflammation
Study to evaluate the effects of brexanolone and lorazepam on the nervous system in healthy male participants using magnetic brain stimulation

Not recruiting

1 1 1
Investigated drugs:
- Lorazepam
A study to compare how the body absorbs empagliflozin tablets in healthy individuals.

Not recruiting

1 1 1 1
Investigated drugs:
- Empagliflozin
A study to compare the absorption of apixaban capsules and apixaban tablets in healthy volunteers to prevent thrombosis.

Not recruiting

1 1 1 1
Investigated diseases:
- Thrombosis
Investigated drugs:
- Apixaban
Comparison of montelukast 10 mg capsules and montelukast 10 mg film-coated tablets in healthy volunteers to evaluate how the medicine is absorbed.

Not recruiting

1 1 1 1
Investigated diseases:
- Asthma
Investigated drugs:
- Montelukast
Efficacy and Safety Evaluation of Belantamab Mafodotin Versus Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients

Not recruiting

3 1 1 1
Investigated diseases:
- Plasma cell myeloma
Investigated drugs:
+4
A study to evaluate how the body processes AZ-3102 in healthy male subjects

Not recruiting

1 1 1
Investigated drugs:
- (2S,3R,4R,5S)-1-[5-(2-FLUORO-BIPHENYL-4-YLMETHOXY)-PENTYL]-2-HYDROXYMETHYL-PIPERIDINE-3,4,5-TRIOL
Phase 3 Study of Subcutaneous Pembrolizumab with Hyaluronidase vs. Intravenous Pembrolizumab in Metastatic NSCLC with PD-L1 TPS ≥50%

Not recruiting

3 1 1 1
Investigated diseases:
- Non-small cell lung cancer metastatic
Investigated drugs:
- Pembrolizumab
A study to compare the safety of ketamine hydrochloride and esketamine in healthy men for the treatment of depression

Not recruiting

1 1 1
Investigated diseases:
- Major depression
Investigated drugs:
- Esketamine Hydrochloride
- Ketamine Hydrochloride
A study to evaluate how lazertinib is absorbed in healthy adults to support future treatment for non-small cell lung cancer.

Not recruiting

1 1 1
Investigated diseases:
- Non-small cell lung cancer
Investigated drugs:
- Lazertinib

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies